Skip to content

The safety and effectiveness of multi-disciplinary remote robot-assisted surgery was studied by means of endoscopy system

The safety and effectiveness of multi-disciplinary remote robot-assisted surgery was studied by means of endoscopy system

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082241
Enrollment
Unknown
Registered
2024-03-25
Start date
2024-04-01
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecology surgery,Thoracic surgery,General surgery

Interventions

Sponsors

Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1)18 years old =80 years old; (2) Endoscopic thoracic/abdominal surgery is required, with indications for corresponding surgical treatment, including but not limited to the following operations: a. Gynecology: radical hysterectomy plus pelvic lymph node dissection, hysterectomy, adnexectomy; b. General surgery: radical resection of distal gastric cancer, total gastrectomy, radical resection of colorectal cancer, hepatectomy, cholecystectomy, gastric volume reduction; c. Thoracic surgery: segmental/lobectomy, mediastinal tumor resection; (3) Patients with physical condition who can accept thoracic/laparoscopic surgery; (4) Willing to cooperate with and complete the study follow-up and related tests; (5) The subjects or their agents voluntarily participate in the experiment and sign the informed consent in person.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) The clinical stage of malignant tumor is IV; (3) Patients in need of emergency surgery; (4) Active bleeding, severe coagulation dysfunction (prothrombin time (PT) or International normalized ratio (INR) higher than 1.5 times the upper limit of normal) or platelet count < 80×109/L; (5) Patients with serious cardiovascular or circulatory diseases who cannot tolerate surgery; (6) Participants in other clinical trials within the last 1 month; (7) Unable to understand the trial requirements, or unable to complete the study follow-up plan; (8) The researcher believes that there are other circumstances that are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
Remote surgery success rate;Incidence of device-related or potentially device-related complications (Grade 3 or higher) within 30 days;

Secondary

MeasureTime frame
Network transmission evaluation;Robot-assisted surgery time;EBL;VAS;Blood transfusion rate;Length of stay;

Countries

China

Contacts

Public ContactXiuJun Cai

Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine

srrsh_cxj@zju.edu.cn+86 571 8609 0073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026